Combination therapy: Opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines
Top Cited Papers
- 20 August 2009
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 61 (13), 1203-1213
- https://doi.org/10.1016/j.addr.2009.05.006
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Targeting Angiogenesis-Dependent Calcified Neoplasms Using Combined Polymer TherapeuticsPLOS ONE, 2009
- Combination Therapy With Glucagon-Like Peptide-1 and Gastrin Restores Normoglycemia in Diabetic NOD MiceDiabetes, 2008
- Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapyBritish Journal of Cancer, 2008
- Combination Chemotherapy and Photodynamic Therapy with Fab′ Fragment Targeted HPMA Copolymer Conjugates in Human Ovarian Carcinoma CellsMolecular Pharmaceutics, 2008
- Polymer conjugates as therapeutics: future trends, challenges and opportunitiesExpert Opinion on Drug Delivery, 2008
- Polymer-drug conjugates: Recent development in clinical oncologyAdvanced Drug Delivery Reviews, 2008
- Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast CancerNew England Journal of Medicine, 2007
- Dendritic systems in drug delivery applicationsExpert Opinion on Drug Delivery, 2007
- Polymer-drug conjugates as modulators of cellular apoptosisThe AAPS Journal, 2007
- HIV infection, HAART, and endothelial adhesion molecules: current perspectivesThe Lancet Infectious Diseases, 2004